Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Pharmacological therapy for Wegener's granulomatosis.

White ES, Lynch JP.

Drugs. 2006;66(9):1209-28. Review.

2.

Wegener's granulomatosis: an update on diagnosis and therapy.

Manna R, Cadoni G, Ferri E, Verrecchia E, Giovinale M, Fonnesu C, Calò L, Armato E, Paludetti G.

Expert Rev Clin Immunol. 2008 Jul;4(4):481-95. doi: 10.1586/1744666X.4.4.481.

PMID:
20477576
3.

Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.

Lynch JP 3rd, Tazelaar H.

Semin Respir Crit Care Med. 2011 Jun;32(3):274-97. doi: 10.1055/s-0031-1279825. Epub 2011 Jun 14.

PMID:
21674414
4.

Wegener's granulomatosis: evolving concepts in treatment.

Lynch JP 3rd, White E, Tazelaar H, Langford CA.

Semin Respir Crit Care Med. 2004 Oct;25(5):491-521.

PMID:
16088495
5.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Lee RW, D'Cruz DP.

Drugs. 2008;68(6):747-70. Review.

PMID:
18416584
6.

Treatment options for refractory Wegener's granulomatosis: a role for rituximab?

Antoniu SA.

Curr Opin Investig Drugs. 2007 Nov;8(11):927-32. Review.

PMID:
17979026
7.

[Wegener's granulomatosis: diagnosis and treatment].

Vera-Lastra O, Olvera-Acevedo A, McDonal-Vera A, Pacheco-Ruelas M, Gayosso-Rivera JA.

Gac Med Mex. 2009 Mar-Apr;145(2):121-9. Review. Spanish.

PMID:
19518019
8.

Treatment of Wegener's granulomatosis.

Regan MJ, Hellmann DB, Stone JH.

Rheum Dis Clin North Am. 2001 Nov;27(4):863-86, viii. Review.

PMID:
11723769
9.

[Wegener's granulomatosis and microscopic polyangiitis].

de Groot K, Reinhold-Keller E.

Z Rheumatol. 2009 Feb;68(1):49-63; quiz 64. doi: 10.1007/s00393-008-0425-z. Review. German.

PMID:
19184066
10.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

11.
12.

Design of the Wegener's Granulomatosis Etanercept Trial (WGET).

WGET Research Group..

Control Clin Trials. 2002 Aug;23(4):450-68.

PMID:
12161090
13.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

14.

Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.

Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS.

Arthritis Rheum. 2001 May;44(5):1149-54.

15.

Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis.

Lamprecht P, Voswinkel J, Lilienthal T, Nolle B, Heller M, Gross WL, Gause A.

Rheumatology (Oxford). 2002 Nov;41(11):1303-7.

PMID:
12422004
16.

Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

Stone JH; Wegener's Granulomatosis Etanercept Trial Research Group..

Arthritis Rheum. 2003 Aug;48(8):2299-309.

17.

Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.

Seo P, Specks U, Keogh KA.

J Rheumatol. 2008 Oct;35(10):2017-23. Epub 2008 Aug 1.

PMID:
18688911
18.

Wegener's granulomatosis of the prostate gland.

Gunnarsson R, Omdal R, Kjellevold KH, Ellingsen CL.

Rheumatol Int. 2004 Mar;24(2):120-2. Epub 2003 Jul 15.

PMID:
12879271
19.

Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.

Kleinert J, Lorenz M, Köstler W, Hörl W, Sunder-Plassmann G, Soleiman A.

Wien Klin Wochenschr. 2004 May 31;116(9-10):334-8.

PMID:
15237661
20.

Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.

Cadoni G, Prelajade D, Campobasso E, Calŏ L, Agostino S, Manna R, Paludetti G.

Acta Otolaryngol. 2005 Oct;125(10):1105-10.

PMID:
16298794

Supplemental Content

Support Center